Continue to Site

Thread debuts new decentralized clinical trial offering

By Brian Buntz | September 8, 2021

Cary, North Carolina–based Thread has introduced a consultative service known as Thread Adopt to support change management in decentralized clinical trials.

The service encompasses processes, tools, templates and educational functionality.

“Thread Adopt guides and empowers customers to analyze their pipeline, with a view to match decentralized solutions and services to the specific needs of their trials,” said Dr. Christopher Watson, the company’s director of consulting, in a statement.

In late August, Thread announced a partnership with Endpoint Clinical, a provider of interactive response technology for clinical trials, to help clients streamline decentralized clinical trial operations.

The partnership supports two-way integration for eConsent, screening and randomization, while providing automation of workflows across both companies’ respective platforms.

Filed Under: clinical trials, Drug Discovery
Tagged With: decentralized clinical trial, Thread

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.